NEOSTIGMINE METHYLSULFATE INJECTION LIQUID
Country: Canada
Language: English
Source: Health Canada
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
NEOSTIGMINE METHYLSULFATE
Available from:
FRESENIUS KABI CANADA LTD
ATC code:
N07AA01
INN (International Name):
NEOSTIGMINE
Dosage:
1MG
Pharmaceutical form:
LIQUID
Composition:
NEOSTIGMINE METHYLSULFATE 1MG
Administration route:
INTRAMUSCULAR
Units in package:
10ML
Prescription type:
Prescription
Therapeutic area:
PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS
Product summary:
Active ingredient group (AIG) number: 0102263003; AHFS:
Authorization status:
CANCELLED PRE MARKET
Authorization date:
2021-06-28
